Ortho Clinical Diagnostic Q4 EPS $0.18 Beats $0.15 Estimate, Sales $521.00M Miss $521.17M Estimate

Author: Benzinga Newsdesk | February 16, 2022 04:18pm
Ortho Clinical Diagnostic (NASDAQ:OCDX) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.15 by 20 percent. This is a 5.26 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $521.00 million which missed the analyst consensus estimate of $521.17 million by 0.03 percent. This is a 0.85 percent increase over sales of $516.60 million the same period last year.

Posted In: OCDX